Boston Scientific Corp
BSX· NYSE
BSXBoston Scientific Corp
Source filing unavailable
| Metric | Q2 2009 | Q2 2008 |
|---|---|---|
| Revenue | $2.07B | $2.02B |
| Net Income | $158.00M | $98.00M |
| EPS Diluted | $0.10 | $0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
